That was always part of the deal with Purdue...IMO its a positive sign for P3 results...Purdue has invested $20 mil and by this move they will own aprox. 30% of NVLT. I think its a good move because it ties up shareholders for a buyout if they want to go private and helps to wield voting rights if Pfizer comes knocking. Se everyone at @ $20.
Also, these shares/warrants are being held by Purdue...a pharm co. Not a financier. FWIW
It ddss was looking alright until rod Friday..I think ddss could possibly even see lower than 1.80 considering there hasn't been a public offering or raising of capital... Who knows, all these biotechs are tricky and most don't stay up long. Ddss is about to relase earnings so I'm waiting for that before making anymore moves
Market Data 
Markets 
AI
